Literature DB >> 26722540

FRZB up-regulated in hepatocellular carcinoma bone metastasis.

Jia Huang1, Wenhao Hu1, Xiangjin Lin2, Xuanwei Wang2, Ketao Jin3.   

Abstract

The clinical relevance of frizzled-related protein (FRZB) in hepatocellular carcinoma (HCC) bone metastasis remains uncertain. The aim of this study was to assess the clinical relationship of FRZB in patients with HCC bone metastasis after surgical resection. FRZB expression was evaluated by immunohistochemistry in formalin-fixed paraffin embedded (FFPE) HCC and paired bone metastasis tissues from 13 patients that underwent surgical resection. The clinical characteristics of 13 HCC patients with synchronous or metachronous bone metastasis received surgery were retrospectively reviewed. We found that FRZB was positive in 9 HCC tissues (69.2%) and in 11 paired bone metastatic tissues (84.6%) among these 13 paired samples. The expression of FRZB in the bone metastases was noticeably higher than that in the paired HCC tissues. The expression of FRZB was up-regulated in 10 (76.9%) paired bone metastases tissues. FRZB expression was up-regulated in HCC bone metastasis tissue, which suggested that FRZB might play a key role in the HCC bone metastasis.

Entities:  

Keywords:  Hepatocellular carcinoma; bone metastasis; frizzled-related protein (FRZB)

Mesh:

Substances:

Year:  2015        PMID: 26722540      PMCID: PMC4680485     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  29 in total

1.  Unusual metastases of hepatocellular carcinoma (hcc) to bone and soft tissues of lower limb.

Authors:  Zubair Ahmad; Aziz Un Nisa; Zeeshan Uddin; Najamul Sahar Azad
Journal:  J Coll Physicians Surg Pak       Date:  2007-04       Impact factor: 0.711

2.  FRZB knockdown upregulates β-catenin activity and enhances cell aggressiveness in gastric cancer.

Authors:  Shuai Qin; Zhuo Zhang; Jianfang Li; Lu Zang
Journal:  Oncol Rep       Date:  2014-03-24       Impact factor: 3.906

Review 3.  Hepatitis B virus-related cirrhosis: natural history and treatment.

Authors:  Chia-Ming Chu; Yun-Fan Liaw
Journal:  Semin Liver Dis       Date:  2006-05       Impact factor: 6.115

4.  Hepatocellular carcinoma with extrahepatic metastasis: clinical features and prognostic factors.

Authors:  Koji Uchino; Ryosuke Tateishi; Shuichiro Shiina; Miho Kanda; Ryota Masuzaki; Yuji Kondo; Tadashi Goto; Masao Omata; Haruhiko Yoshida; Kazuhiko Koike
Journal:  Cancer       Date:  2011-03-22       Impact factor: 6.860

5.  Frzb, a secreted protein expressed in the Spemann organizer, binds and inhibits Wnt-8.

Authors:  S Wang; M Krinks; K Lin; F P Luyten; M Moos
Journal:  Cell       Date:  1997-03-21       Impact factor: 41.582

6.  Role of secreted frizzled-related protein 3 in human renal cell carcinoma.

Authors:  Hiroshi Hirata; Yuji Hinoda; Koji Ueno; Shahana Majid; Sharanjot Saini; Rajvir Dahiya
Journal:  Cancer Res       Date:  2010-02-16       Impact factor: 12.701

7.  Survival of patients with skeletal metastases from hepatocellular carcinoma after surgical management.

Authors:  H S Cho; J H Oh; I Han; H-S Kim
Journal:  J Bone Joint Surg Br       Date:  2009-11

8.  Prevalence of metastases in hepatocellular carcinoma: risk factors and impact on survival.

Authors:  Ming-Sing Si; Farin Amersi; S Raymond Golish; Jorge A Ortiz; Joseph Zaky; Debbie Finklestein; Ronald W Busuttil; David K Imagawa
Journal:  Am Surg       Date:  2003-10       Impact factor: 0.688

9.  Bone metastasis from primary hepatocellular carcinoma: characteristics of soft tissue formation.

Authors:  Sangwon Kim; Mison Chun; Heejung Wang; Sungwon Cho; Young-Taek Oh; Seung-Hee Kang; Juno Yang
Journal:  Cancer Res Treat       Date:  2007-09-30       Impact factor: 4.679

10.  Methylation and loss of Secreted Frizzled-Related Protein 3 enhances melanoma cell migration and invasion.

Authors:  Elin J Ekström; Victoria Sherwood; Tommy Andersson
Journal:  PLoS One       Date:  2011-04-08       Impact factor: 3.240

View more
  5 in total

Review 1.  Bone metastasis of hepatocellular carcinoma: facts and hopes from clinical and translational perspectives.

Authors:  Zhao Huang; Jingyuan Wen; Yufei Wang; Shenqi Han; Zhen Li; Xuemei Hu; Dongling Zhu; Zhenxiong Wang; Junnan Liang; Huifang Liang; Xiao-Ping Chen; Bixiang Zhang
Journal:  Front Med       Date:  2022-07-19       Impact factor: 9.927

2.  Emerging Perspectives of Bone Metastasis in Hepatocellular Carcinoma.

Authors:  Xiaofeng Yuan; Ming Zhuang; Xi Zhu; Dong Cheng; Jie Liu; Donglin Sun; Xubin Qiu; Yunjie Lu; Kurt Sartorius
Journal:  Front Oncol       Date:  2022-06-29       Impact factor: 5.738

3.  HBO1 overexpression is important for hepatocellular carcinoma cell growth.

Authors:  Wenhui Zhong; Heping Liu; Li Deng; Guohua Chen; Yubin Liu
Journal:  Cell Death Dis       Date:  2021-05-26       Impact factor: 8.469

4.  CircCNIH4 inhibits gastric cancer progression via regulating DKK2 and FRZB expression and Wnt/β-catenin pathway.

Authors:  Qi Shi; Chuanwen Zhou; Rui Xie; Miaomiao Li; Peng Shen; Yining Lu; Shijie Ma
Journal:  J Biol Res (Thessalon)       Date:  2021-08-07       Impact factor: 1.889

5.  Atypical cyclin P regulates cancer cell stemness through activation of the WNT pathway.

Authors:  Abril Sánchez-Botet; Eva Quandt; Núria Masip; Rubén Escribá; Laura Novellasdemunt; Laura Gasa; Vivian S W Li; Ángel Raya; Josep Clotet; Mariana P C Ribeiro
Journal:  Cell Oncol (Dordr)       Date:  2021-10-04       Impact factor: 7.051

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.